Skip to main content
. 2015 Dec;5(4):681–690. doi: 10.1086/683811

Figure 6.

Figure 6

Summary of bone morphogenetic protein receptor II (BMPR2) mutation influence on development of pulmonary hypertension associated with pulmonary fibrosis, potentially mediated through reactive oxygen species (ROS) production and stabilization of hypoxia-inducible factor (HIF)1-α.